SH3GL1 and diffuse large B-cell lymphoma: Altogether, these results revealed that doxorubicin facilitated the upregulation of SH3GL1, and the overexpression of SH3GL1 inhibited doxorubicin‐induced ferroptosis, thereby reducing the sensitivity of DLBCL cells to doxorubicin.